Yuhong She

2.6k citations

16 papers · 2.1k indexed · 1 hit paper · h-index 15

Impact in

Oncology top 2%
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
Molecular Biology top 5%
- Melanoma and MAPK Pathways
- Heat shock proteins research
- PI3K/AKT/mTOR signaling in cancer

Papers in

Oncology 8
- Cancer-related Molecular Pathways 3
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 2
Pathology and Forensic Medicine 4
- Cancer Mechanisms and Therapy 3

Co-authors: David B. Solit Jose Lobo Neal Rosen Ayana Sawai Gad Getz Iman Osman Qing Ye Christine A. Pratilas
Journals: Journal of Clinical Investigation (2 papers)Molecular Carcinogenesis (1 paper)Clinical Cancer Research (1 paper)Journal of Medicinal Chemistry (1 paper)Nature (1 paper)
Partner nations: United States France Canada

In The Last Decade

Yuhong She

16 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

BRAF mutation predicts sensitivity to MEK inhibition 2005 · 1.0k citations

Peers

Countries citing papers authored by Yuhong She

Since Specialization

Citations

This map shows the geographic impact of Yuhong She's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhong She with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhong She more than expected).

Fields of papers citing papers by Yuhong She

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhong She. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhong She. The network helps show where Yuhong She may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuhong She, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuhong She Line = papers co-authored together Yuhong She links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Maitake Beta-Glucan Enhances Umbilical Cord Blood Stem Cell Transplantation in the NOD/SCID Mouse Experimental Biology and Medicine ·Hong Lin, Elisa de Stanchina, Xi Kathy Zhou, Yuhong She, Danthanh Hoang, Sandy Cheung, Barrie R. Cassileth, Susanna Cunningham–Rundles	2009	8
2	Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer Nature Chemical Biology ·Anna Rodina, Maria Vilenchik, Kamalika Moulick, Julia Aguirre, Joungnam Kim, Anne Chiang, Julie Litz, Cristina C. Clement, Yanlong Kang, Yuhong She, Nian Wu, Sara J. Felts, Peter Wipf, Joan Massagué, Xuejun Jiang, Jeffrey L. Brodsky, Geoffrey W. Krystal, Gabriela Chiosis	2007	129
3	BRAF mutation predicts sensitivity to MEK inhibition Nature ·David B. Solit, Levi A. Garraway, Christine A. Pratilas, Ayana Sawai, Gad Getz, Andrea Basso, Qing Ye, Jose Lobo, Yuhong She, Iman Osman, Todd R. Golub, Judith S. Sebolt–Leopold, William R. Sellers, Neal Rosen Hit paper breakdown →	2005	1013
4	Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90 Journal of Medicinal Chemistry ·Huazhong He, Danuta Zatorska, Joungnam Kim, Julia Aguirre, Laura Llauger, Yuhong She, Nian Wu, Robert M. Immormino, D.T. Gewirth, Gabriela Chiosis	2005	137
5	Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is Significantly More Effective than Continuous Dosing for Sensitizing Tumors to Paclitaxel Clinical Cancer Research ·David B. Solit, Yuhong She, Jose Lobo, Mark G. Kris, Howard I. Scher, Neal Rosen, Frank Sirotnak	2005	112
6	Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics Journal of Clinical Investigation ·Mona D. Lee, Yuhong She, Michael J. Soskis, Christopher P. Borella, Jeffrey R. Gardner, Paula A. Hayes, Benzon M. Dy, Mark Heaney, Mark R. Philips, William G. Bornmann, Francis M. Sirotnak, David A. Scheinberg	2004	83
7	Microarray analysis of prostate cancer progression to reduced androgen dependence: Studies in unique models contrasts early and late molecular events Molecular Carcinogenesis ·F. M. Sirotnak, Yuhong She, Nushmia Z. Khokhar, Paula Hayes, William L. Gerald, Howard I. Scher	2004	38
8	Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics Journal of Clinical Investigation ·Mona D. Lee, Yuhong She, Michael J. Soskis, Christopher P. Borella, Jeffrey R. Gardner, Paula A. Hayes, Benzon M. Dy, Mark Heaney, Mark R. Philips, William G. Bornmann, Francis M. Sirotnak, David A. Scheinberg	2004	89
9	Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro International Immunopharmacology ·Hong Lin, Yuhong She, Barrie R. Cassileth, Frank Sirotnak, Susanna Cunningham Rundles	2003	62
10	The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index. PubMed ·Yuhong She, Fei Lee, Jing Chen, Adriana Haimovitz‐Friedman, Vincent A. Miller, Valerie W. Rusch, Mark G. Kris, F. M. Sirotnak	2003	54
11	Activity of a Novel Anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against Human Lymphoma is Superior to Methotrexate and Correlates with Tumor RFC-1 Gene Expression Leukemia & lymphoma ·Eunice S. Wang, Owen A. O’Connor, Yuhong She, Andrew D. Zelenetz, F. M. Sirotnak, Malcolm A.S. Moore	2003	91
12	Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells. PubMed ·Monica Motwani, Carina Rizzo, Francis M. Sirotnak, Yuhong She, Gary K. Schwartz	2003	72
13	The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells. PubMed ·Christoph P. Jung, Monica Motwani, Jeremy Kortmansky, Francis M. Sirotnak, Yuhong She, Mithat Gönen, Adriana Haimovitz‐Friedman, Gary K. Schwartz	2003	39
14	Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells. PubMed ·Monica Motwani, Francis M. Sirotnak, Yuhong She, Thérèse Commes, Gary K. Schwartz	2002	51
15	Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums. PubMed ·Nushmia Z. Khokhar, Yuhong She, Valerie W. Rusch, F. M. Sirotnak	2001	14
16	Augmentation of apoptosis and tumor regression by flavopiridol in the presence of CPT-11 in Hct116 colon cancer monolayers and xenografts. PubMed ·Monica Motwani, Christoph P. Jung, Francis M. Sirotnak, Yuhong She, Manish A. Shah, Mithat Gönen, Gary K. Schwartz	2001	97

About Yuhong She

Yuhong She is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Rehabilitation and Biochemistry, having authored 16 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Cancer Mechanisms and Therapy (3 papers), Cancer Treatment and Pharmacology (2 papers), HER2/EGFR in Cancer Research (2 papers), Heat shock proteins research (2 papers), Lung Cancer Treatments and Mutations (2 papers), RNA modifications and cancer (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Oncology (983 citations), Molecular Biology (1.4k citations), Pathology and Forensic Medicine (314 citations), Computational Theory and Mathematics (220 citations) and Cancer Research (208 citations). Yuhong She has collaborated with scholars based in United States, France and Canada. Frequent co-authors include David B. Solit, Jose Lobo, Neal Rosen, Ayana Sawai, Gad Getz, Iman Osman, Qing Ye, Christine A. Pratilas, Levi A. Garraway and William R. Sellers. Their work appears in journals such as Journal of Clinical Investigation, Molecular Carcinogenesis, Clinical Cancer Research, Journal of Medicinal Chemistry and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact